Johnson & Johnson Price Today
Johnson & Johnson
JNJ
Healthcare
$439.29B
💰
Market Cap
34.3
💸
Price to Earnings
$4.9
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
7 |
Strong Buy |
5 |
Hold |
15 |
Sell |
0 |
Strong Sell |
0 |
JNJ Price Forecast Target
169.0 👉 195.0 +15%
JNJ EPS Forecast
4.9 👉 10.2 +108%
Financials
Profit Margin
13 %
Revenue Growth
6.3 %
Dividend
$ 4.76
Held Percent
0.1% - Insiders
70.8% - Institutions
29.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $38.3B
-
💰 Blackrock Inc. $31.2B
-
💰 State Street Corporation $21.7B
-
💰 Geode Capital Management, LLC $7.5B
-
💰 Morgan Stanley $6.2B
Stock Ideas
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …📮FAQ
Some Frequently Asked Questions.
The Johnson & Johnson industry is Drug Manufacturers—General
The Johnson & Johnson sector is Healthcare
The Johnson & Johnson forecasted predicted Price to Earnings PE ratio is 16.5
The Johnson & Johnson Price to Earnings PE ratio is 34.3
The Market Capitalization of Johnson & Johnson is $439.29B
There are total of 2595383016 float shares with 70.8% held by Institutions and 0.1% held by insiders
The MJohnson & Johnson forecasted Earnings per Share EPS is $10.2
The Johnson & Johnson Earnings per Share EPS is 4.9
The Johnson & Johnson company has $63954000000 gross profits with 13 profit margins
The Johnson & Johnson Earnings Growth is 0.089% with 0.069% quarterly earnings growth
The Johnson & Johnson Revenue is $97773002752 with 0.063 revenue growth
The price target for Johnson & Johnson stock is $195.0 for the high target and $148.7 for the low target
The consensus analyst recommendations for Johnson & Johnson is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Johnson & Johnson is Buy, with the following breakdown:
- Buy: 7
- Strong Buy: 5
- Hold: 15
- Sell: 0
- Strong Sell: 0
The Beta of Johnson & Johnson is 0.5
The dividend of Johnson & Johnson is $4.76
The dividend yield of Johnson & Johnson is 0.028199999%
The biggest institutional and mutual fund holders of Johnson & Johnson stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- Geode Capital Management, LLC
The Johnson & Johnson ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0